Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPBAR1 | Q8TDU6 | 7/20 | 0.77 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.38 |
| ▸ | CTSA | P10619 | 8/20 | 0.36 |
| ▸ | GAA | P10253 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MGAM | O43451 | 1/20 | 0.33 |
| ▸ | SI | P14410 | 1/20 | 0.33 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.33 |
| ▸ | BRD4 | O60885 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1389749 | 0.94 | GPBAR1 (0.78) | GPBAR1NR3C2CTSAGAA | |
| SCHEMBL1389746 | 0.94 | GPBAR1 (0.78) | GPBAR1NR3C2CTSAGAA | |
| SCHEMBL362360 | 0.94 | GPBAR1 (0.78) | GPBAR1NR3C2CTSAGAA | |
| SCHEMBL1389747 | 0.94 | GPBAR1 (0.78) | GPBAR1NR3C2CTSAGAA | |
| SCHEMBL1390179 | 0.92 | GPBAR1 (0.76) | GPBAR1NR3C2CTSAGAAALDH1A1 | |
| SCHEMBL1390180 | 0.92 | GPBAR1 (0.76) | GPBAR1NR3C2CTSAGAAALDH1A1 | |
| SCHEMBL1390178 | 0.92 | GPBAR1 (0.76) | GPBAR1NR3C2CTSAGAAALDH1A1 | |
| SCHEMBL1390175 | 0.92 | GPBAR1 (0.76) | GPBAR1NR3C2CTSAGAAALDH1A1 | |
| SCHEMBL364580 | 0.91 | GPBAR1 (0.74) | GPBAR1NR3C2CTSAGAAALDH1A1 | |
| SCHEMBL363961 | 0.91 | GPBAR1 (0.74) | GPBAR1NR3C2CTSAGAAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012007365-A1 | 1-HYDROXYIMINO-3-PHENYL-PROPANES | F. HOFFMANN-LA ROCHE AG (CH) | 2012-01-19 | — | — | WO | disclosed |